Announcing the Next Round of AIAC Grant Opportunities

I am pleased to announce a second round of internal grant opportunities through our Academic Investment Advisory Committee (AIAC) Tier 3 funding process. The Tier 3 funding is a direct and significant outcome from the Medical School’s partnership with Fairview Health Services and will continue to grow and strengthen the M Health Fairview partnership. Our purpose is to invest in our academic mission and our faculty in order to advance health and healthcare through the Medical School and our academic health system.

The winter 2020 AIAC awards will advance each of our three missions to energize and catalyze new areas of health research, promote innovation in medical education, and improve clinical care. Each Tier 3 program will focus on specific priorities to achieve our goals. We have expanded the opportunities in this round, thanks to helpful feedback, in order to reach more faculty impacting our mission in different and equally important ways.

Academic Investment Clinical Quality Program (AICP)
In recognition of our significant needs in advancing our quality work, the AICP in this round will focus on a project(s) that improves observed mortality rates due to sepsis.

Academic Investment Education Program (AIEP)
We will expand opportunities through the AIEP to include grants focusing both on high-impact, high-yield return on investment for our education programs, as well as smaller scale grants that catalyze and stimulate new and exciting areas to research, scholarly, and creative work in our education programs.

Academic Investment Research Program (AIRP)
The AIRP will provide funding for successful projects in four categories: 1) Center/program projects from interdisciplinary teams of accomplished investigators; 2) Individual investigator awards for junior faculty; 3) Proposals from interdisciplinary teams for equipment purchases and grant support assistance that will benefit investigators across the Medical School; and 4) Small-scale research projects from Master Clinicians or faculty on the academic track.

Again, we are grateful for the robust participation in our first round and are impressed with the high-quality proposals. We intend to continue that momentum with this round and encourage innovative ideas from Medical School faculty from all ranks.

For questions, please contact Vice Dean Tim Schacker (AIRP), Vice Dean Mark Rosenberg (AIEP) and Dr. Sayeed Ikramuddin (AICP).

Share this post

Related News

  • Transplant Expert Becomes Transplant Minnesotan

    Andrew Adams, MD, PhD, has joined the Department of Surgery as a professor and as chief of the Division of Transplantation at both M Health Fairview University of Minnesota hospitals. He brings $11.7 million in funding from the National Institutes of Health focused on developing novel therapies to improve outcomes for transplant patients.

  • Study Analyzes if Telemedicine is Efficacious in Treating Opioid Use Disorder

    Federal and state agencies have temporarily allowed unprecedented flexibility for the use of telemedicine, including audio-only visits, for encounters where opioid use disorder (OUD) medications are prescribed. Cuong Pham, MD, an assistant professor in the Department of Medicine, is analyzing telemedicine’s efficacy for patients with OUD during COVID-19.

  • Researchers Study Cortisol Levels, Decision-Making in COVID-19 Healthcare Workers

    Alexander Herman, MD, PhD, in the Department of Psychiatry and Behavioral Sciences, and David Darrow, MD, MPH, in the Department of Neurosurgery, are studying hair samples from frontline healthcare workers during the COVID-19 pandemic to determine how their cortisol levels might correlate with their responses on a multi-armed bandit task.”